Skip to main content

Table 1 Socio-demographic and baseline characteristics according to stroke mechanism in French Guiana. India study-French Guiana

From: The epidemiology and management of stroke in French Guiana

Characteristics

All patients

N = 298

Ischemic stroke

N = 234 [78.5%]

Intracerebral hemorrhage

N = 64 [21.4%]

Demographic characteristics

 Age

  < 50

60 (20.1)

43 (18.3)

17 (26.5)

  50–65

106 (35.5)

86 (36.7)

20 (31.2)

  65–80

96 (32.2)

77 (32.9)

19 (29.6)

  ≥80

36 (12)

28 (11.9)

8 (12.5)

 Male gender

190 (63.7)

146 (62.3)

44 (68.7)

Preexisting conditions

 BMI±

  <  20

16 (5.3)

11 (4.7)

5 (7.8)

  20–25

82 (27.5)

60 (25.6)

22 (34.3)

  25–30

82 (27.5)

68 (29)

14 (21.8)

  > = 30

52 (17.4)

41 (17.5)

11 (17.1)

  Unknown

66 (22.1)

54 (23)

12 (18.7)

 Hypertension±

208 (70.2)

164 (70.3)

44 (69.8)

 Diabetes±

74 (24.9)

67 (28.7)

7 (10.9)

 Hypercholesterolemia±

50 (17)

42 (18.1)

8 (12.7)

 Chronic heart failure±

16 (5.4)

12 (5.1)

4 (6.2)

 Alcohol ≥ 2 drinks/day±

52 (17.9)

35 (15.2)

17 (27.8)

 Tobacco status±

  Current smoker

64 (21.6)

53 (22.7)

11 (17.7)

  Previous smoker

48 (16.2)

37 (15.8)

11 (17.7)

  Non smoker

183 (62)

143 (61.3)

40 (64.5)

 Atrial fibrillation±

19 (6.5)

17 (7.4)

2 (3.1)

 Prior medical history

  Prior transient ischemic attack

33 (11)

33 (14.1)

0

  Prior myocardial infarction

8 (2.6)

5 (2.1)

3 (4.6)

  Prior angina pectoris

9 (3)

6 (2.5)

3 (4.6)

  Prior history of lower limb arteriopathy

13 (4.3)

13 (5.5)

0

  Prior history of vascular surgery

7 (2.3)

7 (2.9)

0

  Prior history of angioplasty

7 (2.3)

6 (2.5)

1 (1.5)

 Pre-morbid treatment

  Antiplatelet therapy

41 (13.7)

34 (14.5)

7 (10.9)

  Anticoagulant therapy±

19 (6.4)

10 (4.3)

9 (14)

  Antihypertensive drug±

153 (51.6)

120 (51.7)

33 (51.5)

  Statin±

38 (12.7)

31 (13.3)

7 (10.9)

  Oral antidiabetic drug±

48 (16.2)

44 (18.9)

4 (6.2)

  Psychotropic drug±

15 (5)

9 (3.8)

6 (9.3)

  Insulin±

24 (8)

21 (9)

3 (4.6)

  Oral contraception ±(woman only)

7 (6.4)

7 (7.9)

0

  Substitution hormonotherapy ±(woman only)

2 (1.9)

0

2 (1.9)

 Ischaemic stroke classification (n = 234)

  Lacunar

 

57 (24.3)

 

  Large-artery

 

38 (16.2)

 

  Cardioembolism

 

28 (11.9)

 

  Other

 

111 (47.4)

 

 Admission NIHSS score±

  0–3

89 (31.4)

75 (33.7)

14 (22.9)

  4–9

97 (34.2)

84 (37.8)

13 (21.3)

  ≥10

97 (34.2)

63 (28.3)

34 (55.7)

 mRS at discharge±

  0

40 (14.3)

37 (17.1)

3 (4.8)

  1–2

102 (36.6)

88 (40.7)

14 (22.5)

  3–4

96 (34.5)

67 (31)

29 (46.7)

  1. ± missing values: BMI = 66; HTA = 2; Diabetes = 1; Hypercholesterolemia = 4; Chronic heart failure = 3; Alcohol = 8;Tobbaco = 3; AF = 6; anticoagulant = 2; antihypertensive = 2; statin = 1; oral antidiabetic = 2; psychotropic = 1; insulin = 1; oral contraception = 2; Sub hormonotherapy = 4; pre stroke mRS = 1; NIHSS at admission = 15; Barthel score = 2